ARCHIVES

Cancer Programs Close Amid Gridlock

This article is from The Cancer Letter archive.

Vol. 39 No. 37 | October 4, 2013

Download PDF Visit The Full Archive

Related Articles

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

December 4, 1998

NCAB, Hammer Agree On how 41 Billion To Be Handled: No String Attached

October 14, 1988

Raub Corrects Record on ALERT

April 20, 1984

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001